Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test becomes the only FDA approved companion diagnostic indicated to aid assessment of HER2 low-metastatic breast cancer ...

Roche is the recipient of the new approval, getting the go-ahead from the US regulator for its PATHWAY HER2 (4B5) test to detect HER2-ultralow status in metastatic breast cancer patients ...

In this section you'll find photographic features that explore holidays and photography courses, details about members meetings, trials and tribulations of installing new software along with ...

JUPITER, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- Prostate health is one of the most overlooked yet critical concerns for men over 40, yet most available solutions offer nothing but temporary ...

PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHC"), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo; President ...

SWEET7 is making big moves in Metro Vancouver, and this time, it's Richmond's turn to get in on the action. After debuting its first North American location in Downtown Vancouver last year, the ...

Urban Edge Properties (NYSE: UE) announced today that it will release its first quarter earnings prior to the market open on Wednesday, April 30, 2025. The Company will host an earnings conference ...

Notice: The list of clinics below may contain inaccurate or out-of-date entries, including information for clinics that are no longer designated as Yellow Fever Vaccination Centres. We continue to ...